Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Dig Dis Sci

Retrieve available abstracts of 33 articles:
HTML format

Single Articles

    October 2022
    Missing Causality and Heritability of Autoimmune Hepatitis.
    Dig Dis Sci. 2022 Oct 19. pii: 10.1007/s10620-022-07728.
    PubMed     Abstract available

  2. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
    Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.

  3. LIU CH, Jiang W, Wu DB, Zeng QM, et al
    Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Oct 13. pii: 10.1007/s10620-022-07695.
    PubMed     Abstract available

    September 2022
  4. HONMA Y, Shibata M, Morino K, Koya Y, et al
    Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.
    Dig Dis Sci. 2022 Sep 14. pii: 10.1007/s10620-022-07686.
    PubMed     Abstract available

  5. YU Y, Li X, Wan T
    Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis.
    Dig Dis Sci. 2022 Sep 9. pii: 10.1007/s10620-022-07687.
    PubMed     Abstract available

    July 2022
  6. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    PubMed     Abstract available

  7. FANG HW, Yen YH, Hung CH, Wang JH, et al
    Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir.
    Dig Dis Sci. 2022;67:3402-3411.
    PubMed     Abstract available

    June 2022
  8. BERNSTEIN DE, Trinh HN, Schiff ER, Smith CI, et al
    Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
    Dig Dis Sci. 2022;67:2637-2645.
    PubMed     Abstract available

    May 2022
  9. LLOYD C, Leighton J, Wong LL, Goulding A, et al
    Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07525.
    PubMed     Abstract available

  10. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    PubMed     Abstract available

  11. RAO A, Rule JA, Cerro-Chiang G, Stravitz RT, et al
    Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.
    Dig Dis Sci. 2022 May 11. pii: 10.1007/s10620-022-07524.
    PubMed     Abstract available

  12. SHROFF H, Fix OK
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07509.

    April 2022
  13. CHOW KW, Pham NV, Ibrahim BM, Hong K, et al
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature.
    Dig Dis Sci. 2022 Apr 29. pii: 10.1007/s10620-022-07504.
    PubMed     Abstract available

  14. JONES E, Watkins M, Anderson E, Gelow K, et al
    Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life.
    Dig Dis Sci. 2022 Apr 19. pii: 10.1007/s10620-022-07484.
    PubMed     Abstract available

    March 2022
  15. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.

  16. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed     Abstract available

  17. MAK LY, Wong DK, Cheung KS, Hui RW, et al
    Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Mar 8. pii: 10.1007/s10620-022-07429.
    PubMed     Abstract available

  18. SAAB S, Pham N, Wu W, Dang L, et al
    Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naive Chronic Hepatitis B Patients.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07402.
    PubMed     Abstract available

    February 2022
  19. CZAJA AJ
    Advancing Biologic Therapy for Refractory Autoimmune Hepatitis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-021-07378.
    PubMed     Abstract available

    January 2022
  20. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    PubMed     Abstract available

    November 2021
  21. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    PubMed     Abstract available

    September 2021
  22. CHUN HS, Lee JS, Lee HW, Kim BK, et al
    Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
    PubMed     Abstract available

    July 2021
  23. VAZ K, Little R, Majeed A, Kemp W, et al
    Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07140.
    PubMed     Abstract available

  24. TOKA B, Koksal AS, Eminler AT, Tozlu M, et al
    Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.
    Dig Dis Sci. 2021;66:2417-2426.
    PubMed     Abstract available

    June 2021
  25. GELOW K, Chalasani S, Green K, Lammert C, et al
    Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
    Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
    PubMed     Abstract available

    May 2021
  26. CHEN J, Hubbard A, Bagley L, Shiau R, et al
    Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 May 30. pii: 10.1007/s10620-021-07056.
    PubMed     Abstract available

  27. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available

  28. LIN MH, Li HQ, Zhu L, Su HY, et al
    Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
    PubMed     Abstract available

  29. HE WQ, Matthews GV, Liu B
    Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-07008.
    PubMed     Abstract available

    April 2021
  30. LAMMERT C, Chalasani SN, Green K, Atkinson E, et al
    Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.
    Dig Dis Sci. 2021 Apr 30. pii: 10.1007/s10620-021-06989.
    PubMed     Abstract available

  31. CZAJA AJ
    Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
    Dig Dis Sci. 2021 Apr 9. pii: 10.1007/s10620-021-06968.
    PubMed     Abstract available

  32. CHANG PE, Tan CK, Cheah CC, Li W, et al
    Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:1343-1348.
    PubMed     Abstract available

    February 2021
  33. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.